Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 506

6 January 2021

Fulcrum Utility Services Ltd Directorate Changes

Dean Harris, Chief Executive Officer, has stepped down from his role with immediate effect and is to be replaced by Terry Dugdale, who was appointed as Chief Operating Officer in March 2019. …

6 January 2021

Conygar Investment Company Announces InterContinental Hotel Group for Nottingham Scheme

The Conygar Investment Company has agreed terms with InterContinental Hotels Group at its major Nottingham development site….

6 January 2021

Greggs PLC Trading Update for Fourth Quarter 2020

Greggs announces its trading update for the fourth quarter of 2020….

5 January 2021

Custodian REIT New Property Purchase

Custodian REIT announces a further property purchase….

5 January 2021

GlobalData PLC Change of Board

GlobalData announces today the following Board changes….

5 January 2021

Morrisons Trading Statement

Morrisons trading update with particular focus on performance on the Christmas and New Year period….

5 January 2021

Softcat PLC Announces Trading Update

Softcat PLC updates on trading ahead of its interim results for the six months to 31 January 2021….

4 January 2021

AstraZeneca Complete Divestment of Commercial Rights to Atacand and Atacand Plus in Over 70 Countries

AstraZeneca has completed the divestment of commercial rights to Atacand   ( candesartan cilexetil)   and Atacand   Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide ) in over 70 countries to Cheplapharm Arzneimittel GmbH (Cheplapharm).   Financial considerations…

Posts navigation

  • «
  • 1
  • …
  • 504
  • 505
  • 506
  • 507
  • 508
  • …
  • 904
  • »

Home > Market News > Page 506

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG